Eight Sleep Founders Bet Your Bed Can Diagnose Illness
Eight Sleep, the smart-bed company led by husband-and-wife founders Alexandra Zatarain and Matteo Franceschetti, is now valued at $1.5 billion and is already profitable. Zatarain launched the business in 2014, shortly after her father died of cancer, an illness that took his sleep first. That loss shaped the mission: if sleep is where the body signals trouble early, the bed could become an early health check.
Selling “Sleep Fitness”
Zatarain, who leads brand, growth and communications, coined the term “sleep fitness” to frame sleep as something to train, track and optimise, like a workout. Franceschetti, a former securities lawyer and competitive athlete, brought his own experience of restless-legs-related sleepless nights. Unlike wearables that merely report data, the Pod acts on it overnight, cooling one side of the bed or adjusting its base to ease snoring. A paid membership covers the continuous processing of sleepers’ biometrics.
The numbers support the pitch. A $50 million round led by Tether Investments in March 2026 set the $1.5 billion valuation. The company is free-cash-flow positive, with cumulative Pod sales approaching $1 billion, a presence in 37 countries and more than a billion hours of sleep analysed.
Pod 6 and the Push Into Medicine
The Pod 6, launched on September 23, has a smaller hub, 20% faster cooling and nine times more sensors. It also introduces solo sizes starting at $1,999, the lowest entry price in the company’s history. Eight Sleep is seeking FDA clearance to detect and mitigate sleep apnea, which could make the bed prescribable and reimbursable by insurers. Features such as Hot Flash Mode and Pregnancy Mode target women’s health, a focus Zatarain has made her own.
The founders keep clear lanes: Franceschetti makes final decisions, while Zatarain owns brand and growth. Whether a bed can truly diagnose its sleeper remains to be proven, but the company’s profits give it room to try.